Viking Therapeutics Stock Predictions

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

VKTX
Viking Therapeutics

Last Price:

$26.58

Seasonality Move:

10.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Viking Therapeutics Stock Forecast

Over the next 52 weeks, Viking Therapeutics has on average historically risen by 143% based on the past 9 years of stock performance.
Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Is Viking Therapeutics Stock Undervalued?

The current Viking Therapeutics [VKTX] share price is $27.74. The Score for VKTX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Viking Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Viking Therapeutics has on average historically risen by 143% based on the past 9 years of stock performance.

Viking Therapeutics Stock Rating

Sell

Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics overpriced?

Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Viking Therapeutics Stock Price History

Is VKTX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

vikingtherapeutics.com

52-Week Data

52-Week High:

81.73

52-Week Low:

18.92

Prediction Charts

Market Cap:

3.1B

Price in USD:

27.74

Volume:

3.1M

Beta:

1.38

Technical Analysis

SMA50:

26.48

SMA100:

31.12

SMA200:

45.67

52-Wk Change:

-61.67%

Stock Predictions

Is Viking Therapeutics stock public?

Yes, Viking Therapeutics is a publicly traded company.
What is the Viking Therapeutics stock quote today?

The Viking Therapeutics stock price is 27.74 USD today.
How to buy Viking Therapeutics stock online?

You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-24	26.09	25.66	26.85	24.87
Apr-25	25.14	24.99	25.40	24.36
Apr-28	25.11	25.94	26.42	24.32
Apr-29	27.05	27.94	29.68	26.57
Apr-30	27.48	28.87	29.02	27.06
May-1	28.91	28.62	29.01	27.69
May-2	29.19	29.36	30.28	29.09
May-5	29.07	29.49	29.73	28.70
May-6	29.06	27.01	29.08	26.73
May-7	27.16	27.56	27.66	26.90
May-8	27.51	27.85	28.65	26.37
May-9	27.97	27.55	28.73	27.45
May-12	28.27	28.30	28.98	27.68
May-13	28.25	27.74	28.28	26.81

Viking Therapeutics Earnings

Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Viking Therapeutics Forecast Revenue Growth

Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.28 per share, a decrease this year of $0.88 per share, and a decrease next year of $0.64 per share.

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.